First 2021 GaBI Journal issue highlights
Biosimilars – status in July 2020 in 16 countries
An assessment of trends in the Iranian pharmaceutical market following domestic production of selected medications (2007‒2017) and new considerations for health policymakers
Continuous manufacturing versus batch manufacturing: benefits, opportunities and challenges for manufacturers and regulators
Δ